MDxHealth SA - Ordinary Shares (MDXH)

Gainers MDxHealth (NASDAQ:MDXH) stock moved upwards by 120.8% to $1.02 during Friday's regular session. The company's market cap stands at $23.7 million. The company's, Q2 earnings came out yesterday.

On Thursday, MDxHealth (NASDAQ:MDXH) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call transcripts and

MDxHealth (MDXH) Q1 2026 Earnings Transcript

MDxHealth (NASDAQ:MDXH) reported first-quarter 2026 revenue of $27.4 million while announcing a strategic exit from its Resolve UTI testing business and the planned closure of its Plano, Texas, laboratory facility, a move executives said will sharpen the company’s focus on prostate cancer diagnostic

MDxHealth (MDXH) Q4 2025 Earnings Call Transcript

MDxHealth (MDXH) Q3 2025 Earnings Call Transcript

MDxHealth reported mixed Q3 2025 results with 18% revenue growth and a key milestone of positive adjusted EBITDA, despite missing top-line estimates.

MDxHealth (MDXH) stock shows strong technical uptrend and fundamental growth momentum, meeting criteria for high-growth investors.

After months of work, we’re proud to release the Master Swing Trading Course - a 175-page deep dive designed from your feedback and our three decades of market experience.